Brief view

1
(No Transcript)
2
Brief view

• Pharmaceutical factory Joint Stock Company
  Borisovskiy Zavod Medicinskikh Preparatov is
  the leading manufacture and the exporter of
  broad-spectrum drugs in the Republic of Belarus.
• The factory was established in 1965. The
  company town of Borisovskiy Zavod Medicinskikh
  Preparatov JSC is above 11 hectares. Total
  employment at the factory is 2700 persons.
  Production volume in the actual prices for 2013
  917.3 billion rubles (103.3 million USD)
• Now JCS Borisovskiy Zavod Medicinskikh
  Preparatov is a modern dynamically developing
  pharmaceutical factory with new technology and
  high quality production and skilled personal.

slide 1
3
Brief view
JSCBZMP holds participating shares in the
companies
slide 2
4

slide 3
5
Brief view

• The core business of Borisovskiy Zavod
  Medicinskikh Preparatov JSC
• Ampoule production and powder for injections in
  vials (antibiotics)
• tablet production
• production of liquid photochemical and soft
  medical drugs
• production of hard capsule drugs
  

slide 4
6
Short summary
Production volume in comparable prices Billions
rubles / growth rate to the previous year
Billons rubles
Production volume in the actual prices in 2012-
747,8 billions rubles, in 2013 917,3 billion
rubles (103,3 million USD).
slide 5
7
Production pattern for 2013
slide 6
8
Export pattern
Republic of Belarus
Russian Federation
Kazakhstan
Uzbekistan
Tajikistan
Turkmenistan
Kyrgyzstan
Ukraine
Moldova
Armenia
Latvia
Lithuania
Estonia
Azerbaijan
Georgia
Afghanistan
USA
Iraq
Somalia
Yemen Lebanon Macedonia



Production was exported to 24 regions
including CIS countries, Russia, nearby and
foreign countries .
Vietnam DPRK EGYPT
slide 7
9
Portion of JSC BZMP in total domestic
production of medical drugs for 2013(million
packs)
1 2 3 4
5 6 7 8 9

BZMP JSC keeps 36 of sales of medical drugs sold
by domestic in the Republic of Belarus (on the
basis of quantities).
slide 8
10
Portion of BZMP JSC in total sales of medical
drugs in the Republic of Belarus for 2013
(million packs)
1 2 3 4 5 6 7 8 9 10 11 12 13
14 15 16 17 18 19 20 21 22 23 24
25
BZMP JSC keeps 26 for sales of medical drugs in
the Republic of Belarus (on the basis of
quantities)
slide 9
11
Export pattern Export ratio () in total volume
exports for 2013, thousand USD
In 2013 export of production amounted to 55.4
million USD.
slide 10
12
Volume of export
In 2013 export volume amounts to 55.4 million
US dollars or 105.6 of the corresponding period
last year.
slide 11
13
TOP - 10
of medical drugs
Rating place Name Sales volume for 2013 (local sales export) In thousand USD
1 Valeriane extract, coated tablets 20 mg, ?50 4527
2 Acetylsalicylic acid, tablets 500 mg ?10 3639
3 Ceftriaxone, powder for injections, 1 g 3436
4 Analgin 50 ?10 2553
5 Citramon-Borimed, tablets ?6 2488
6 Sodium chloride, 0,9 solution for injections, 5ml ?10 1859
7 Cefazolin, powder for injections, 1 g 1833
8 Folic acid, tablets ?50 1655
9 Lidocaine, solution for injections 2 ml 1590
10 Cyanocobalamin , solution for injections 1502
slide 12
14
DEALERS NET

Borisovskiy Zavod
Medicinskikh PreparatovJSC
Structure of dealer net
? ?/? Country Number of dealers
1 Kazakhstan 23
2 Russian Federation 10
3 Uzbekistan 10
4 Moldova 11
5 Georgia 7
6 Azerbaijan 7
7 Other foreign countries 14
8 Turkmenistan 4
9 Kyrgyzstan 3
10 Tajikistan 5
11 Ukraine 2
12 Armenia 2
Total 98
slide 13
15
New medical drugs
Name of drug Pharmacologic
2009 2009
Zovasticor, tabl. Hypolipemic (lowers the level of cholesterol in the blood)
Chloropiramin, sol. for ing. Antihistamine preparation, inhibitor of H1- histamine receptors
Lidocaine, sol. for ing. For solution of cephalosporin antibiotics of III generation
Spasmatone, sol. for ing., tabl Analgesics and antispasmodics, non-narcotic
Ketozoral, tabl. Anti-fungous
Roxitromicyn Borimed, tabl. Antibiotic macrolide
2010 2010
Borinem, sol. for ing. Antibiotic carbopenem
Aspicard, tabl. Non-steroidal anti-inflammatory drugs acetilsalicylic acid
Lansazole, caps. Inhibitor of proton pump
BoriVit, sol. for ing. Hypoglycemic means, decreases sugar in blood
Klindacil, sol. for ing. Antibiotic lincosamides group
2011
Lizinopril-Borimed,tabl. Inhibitor ACE (arterial hypertension, chronicle heart dysfunction)
Ribavirin-Borimed, caps. Intivirus preparation
Metformin-Borimed, tabl. For hypoglycemia treatment, per oral use, group Biguanid
Risperidon-Borimed, tabl. Antipsychotic
Sulpirid, caps. Antipsychotic
Sedative drops Combined sedative preparation
16
New medical drugs
New medical drugs Name of drug Pharmacologic
2012 2012
Metromizol-Dent, gel combined antimicrobial agent for dentistry use
Gliclazide, tabl. 2nd generation sulfonylurea antidiabetic agent
Clindacyl, caps. lincosamide antibiotic
Clarithromycin, tabl. macrolide antibiotic
Bisoprolol, tabl. hypotensive, antiarrythmic and antianginal remedy
Ondansetron, tabl. antiemetic agent
Ethambutol, tabl. antituberculous remedy
Choline Alfascerate, sol. for inj. nootropic agent
slide 15
17
New medical drugs
New medical drugs Name of drug Pharmacologic
2013 2013
Valerianae Forte, tabl. sedative and soporific
Wite tablet, tabl. enterosorbent additional source of dietary fiber
ProctoMaz ointment agent for the treatment of hemorrhoids
Meloxicam, tabl. non-steroidal anti-inflammatory drug
Magnekard,tabl. platelet aggregation inhibitors
slide 16
18
Sales volume pattern in the Republic of Belarus
for 2013
Increase of sales for 2013(compared to 2012)
Total increase of sales for 2013 130,7
(compared to 2012) Amounts to 435.6 billion
rubles ( 49.0 mln. USD)
slide 17
19
Implementation of international standards

• All main production sectors have GMP
  certificate and monitored in accordance with the
  quality standards of GMP.
  
  
• The factory was certified with
• Quality and Operational Health and Safety
  Management Quality Management Systems for medical
  drugs and biologically active additives
  conformity STB ISO 9001 -2009.
• Environment Management Systems for production and
  sales of medical drugs (ecological certificate)
  STB ISO 140012005
• Occupational Health Safety System Certification
  for production and sale of medical drug and
  biologically active additives - STB 18001-2009
• Certificate of Conformity for Production of
  Valeriane extract tablets accordingly to the EC
  standards issued by Latvian Certification Centre.

slide 18
20
Award of the government of the Republic of
Belarus
Award of government of the Republic of Belarus in
the field quality 2011 is awarded to open joint
stock company Borisovskiy Zavod Medicinskikh
Preparatov. The company is awarded for its high
efficient quality management and assurance of
production of quality competitive products.
slide 19
21
Proposal on cooperation

• We offer to create a joint venture on the basis
  of existing sites of JSC BZMP
• 1. Joint venture for production of solutions for
  injections in ampoules
• Collective investment fund 45.5 mln USD
• Participants quotas
• JSC BZMP 25.5 mln
  USD 56.0
• Investor 20.0
  mln USD 44.0
• JSC BZMP
• hands over its existing production sites and
  equipment for production of solutions for
  injections in ampoules
• hands over the whole range of products in the
  form of solutions for injections.
• Investor
• pays the cost of the reconstruction of ampoule
  production
• offers a new range of medical products.

slide 20
22
Proposal on cooperation

• 2. Joint venture for production of medical
  products in the form of tablets
• Collective investment fund 23.2 mln USD
• Participants quotas
• JSC BZMP 8.2 mln USD 35.4
• Investor 15.0 mln USD 64.6
• JSC BZMP
• hands over a part of its existing production
  sites and equipment for production of medical
  products in the form of tablets
• hands over a part of the range of products in the
  form of tablets.
• Investor
• pays the cost of the reconstruction of existing
  tablet production
• offers a new range of medical products.
• We invite you for cooperation!

slide 21
23
Health, the dearest value is trusted to us !
slide 22